Form
20-F þ
|
Form
40-F o
|
Yes
o
|
No
þ
|
EXFO
ELECTRO-OPTICAL ENGINEERING INC.
|
|
By: /s/
Benoit Ringuette
Name: Benoit
Ringuette
Title: General
Counsel and Corporate Secretary
|
|
§
|
Annual
sales increase 19.2% to a record-high US$152.9 million, including
year-over-year growth of 20.3% to US$43.0 million in the fourth
quarter
|
§
|
GAAP
net earnings reach US$42.3 million in fiscal 2007, including recognition
of US$24.6 million in future income tax assets and US$3.2 million in
R&D tax credits
|
§
|
Gross
margin improves for a fifth consecutive year to
57.4%
|
§
|
Receives
fourth consecutive Growth Strategy Leadership Award from Frost &
Sullivan for highest market-share gains in fiber-optic test equipment
market
|
Segmented
results:
|
Q4
2007
|
Q3
2007
|
Q4
2006
|
FY
2007
|
FY
2006
|
|||||||||||||||
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
|||||||||||||||||
Sales:
|
||||||||||||||||||||
Telecom
Division
|
$ |
37,199
|
$ |
33,821
|
$ |
30,111
|
$ |
129,839
|
$ |
107,376
|
||||||||||
Life
Sciences & Industrial Division
|
5,776
|
5,384
|
5,622
|
23,095
|
20,877
|
|||||||||||||||
Total
|
$ |
42,975
|
$ |
39,205
|
$ |
35,733
|
$ |
152,934
|
$ |
128,253
|
||||||||||
Earnings
from operations:
|
||||||||||||||||||||
Telecom
Division
|
$ |
8,108
|
$ |
2,143
|
$ |
1,275
|
$ |
13,132
|
$ |
6,679
|
||||||||||
Life
Sciences & Industrial Division
|
994
|
697
|
1,088
|
3,650
|
1,383
|
|||||||||||||||
Total
|
$ |
9,102
|
$ |
2,840
|
$ |
2,363
|
$ |
16,782
|
$ |
8,062
|
||||||||||
Other
selected information:
|
||||||||||||||||||||
GAAP
net earnings
|
$ |
33,646
|
$ |
2,574
|
$ |
2,910
|
$ |
42,275
|
$ |
8,135
|
||||||||||
Amortization
of intangible assets
|
$ |
699
|
$ |
653
|
$ |
1,043
|
$ |
2,864
|
$ |
4,394
|
||||||||||
Stock-based
compensation costs
|
$ |
277
|
$ |
178
|
$ |
213
|
$ |
981
|
$ |
1,032
|
||||||||||
Impairment
of long-lived assets
|
$ |
−
|
$ |
−
|
$ |
−
|
$ |
−
|
$ |
604
|
||||||||||
Government
grants
|
$ | (1,079 | ) | $ |
−
|
$ |
−
|
$ | (1,079 | ) | $ | (1,307 | ) | |||||||
Recognition
of previously unrecognized future income taxes
|
$ | (24,566 | ) | $ |
−
|
$ |
−
|
$ | (24,566 | ) | $ |
−
|
||||||||
Recognition
of previously unrecognized R&D tax credits
|
$ | (3,162 | ) | $ |
−
|
$ |
−
|
$ | (3,162 | ) | $ |
−
|
§
|
Market
expansion — EXFO increased its sales to an all-time high of
US$152.9 million in fiscal 2007 for an annual growth rate of 19.2%,
while
the company’s published goal was 20%. Telecom Division sales improved
20.9% year over year, including 19.9% in the optical test segment,
48.2%
in the protocol test segment and 15.5% in the copper access test
segment
(although Consultronics contributed only seven month’s revenue in fiscal
2006). Confirming the highest market-share gains in the fiber-optic
test
equipment market, Frost & Sullivan named EXFO recipient of the Growth
Strategy Leadership Award for the fourth consecutive year. In terms
of
market expansion, EXFO’s sales to Europe, Middle East and Africa (EMEA)
and the Americas increased 27.5% and 18.7%, respectively, in fiscal
2007.
The Life Sciences and Industrial Division and Asia-Pacific region
generated lower year-over-year sales growth of 10.6% and 7.8%,
respectively, in 2007.
|
§
|
Profitability
— EXFO completed fiscal 2007 with record-high GAAP net earnings
of US$42.3 million or US$0.61 per diluted share, including US$33.5
million
or US$0.48 per diluted share in the fourth quarter. GAAP net earnings
in
fiscal 2007 included US$24.6 million in recognition of previously
unrecognized future income taxes, US$3.2 million in recognition of
previously unrecognized R&D tax credits, US$2.9 million in
amortization of intangible assets, US$1.1 million from a government
grant
recovery and US$1.0 million in stock-based compensation costs. In
comparison, the company generated US$8.1 million in GAAP net earnings
in
2006. The significant improvement is mainly due to increased revenue
contribution from the Telecom Division and a strong focus on operations,
despite a headwind from a strengthening Canadian dollar. Looking
at GAAP
operating margin, it reached 11.0% of sales in fiscal 2007, while
the
company’s stated goal was 7%. Excluding the recognition of previously
unrecognized R&D tax credits of US$3.2 million and a government
grant recovery of US$1.1 million, operating margin would have attained
8.2% in 2007. EXFO also generated an all-time high of US$14.4 million
in
cash flows from operating activities in 2007, raising its cash and
short-term investments to US$129.8
million.
|
§
|
Innovation
— EXFO introduced 20 new products in fiscal 2007, including
two
in the fourth quarter, compared to 18 in 2006. Two product releases
in the
fourth quarter of 2007 included a high-performance OTDR for
ultra-long-haul network applications and a quality assurance system
for
real-time monitoring of triple-play IP services. Following the
year-end, the company released three additional test solutions:
a multi-service, multi-medium handheld platform for characterizing
and
troubleshooting rapidly growing access networks (AXS-200
SharpTESTER); a compact multi-service transport test set that
combines next-generation SONET/SDH and Ethernet testing inside a
single
module (FTB-8120NGE/FTB-8130NGE Power Blazer); and a cost-effective
handheld tester for the rapid installation and maintenance of
ADSL/ADSL2/ADSL2+ services (EXD-350 ADSL2+ Test Set). Products on the
market two years or less accounted for 33.7% of sales in fiscal 2007,
while the company’s published goal was
35%.
|
Objectives
|
2008
|
2007
|
||
Metrics
|
Metrics
|
Results
|
||
Increase
sales (% of year-over-year growth)
|
20%
|
20%
|
19.2%
|
|
Maximize
profitability (operating margin in %)
|
8%
|
7%
|
11.0%
|
|
Focus
on innovation (sales % from products <2
years
on market)
|
30%
|
35%
|
33.7%
|
As
at
August
31,
2007
|
As
at
August
31,
2006
|
|||||||
(unaudited)
|
||||||||
Assets
|
||||||||
Current
assets
|
||||||||
Cash
|
$ |
5,541
|
$ |
6,853
|
||||
Short-term
investments
|
124,217
|
104,437
|
||||||
Accounts
receivable
|
||||||||
Trade,
less allowance for doubtful accounts of $206
($451
as at August 31, 2006)
|
26,699
|
20,891
|
||||||
Other
|
2,479
|
2,792
|
||||||
Income
taxes and tax credits recoverable
|
6,310
|
2,201
|
||||||
Inventories
|
31,513
|
24,623
|
||||||
Prepaid
expenses
|
1,391
|
1,404
|
||||||
Future
income taxes
|
7,609
|
−
|
||||||
205,759
|
163,201
|
|||||||
Income
taxes recoverable
|
−
|
476
|
||||||
Property,
plant and equipment
|
18,117
|
17,392
|
||||||
Intangible
assets
|
9,628
|
10,948
|
||||||
Goodwill
|
28,437
|
27,142
|
||||||
Future
income taxes
|
17,197
|
−
|
||||||
$ |
279,138
|
$ |
219,159
|
|||||
Liabilities
|
||||||||
Current
liabilities
|
||||||||
Accounts
payable and accrued liabilities
|
$ |
22,721
|
$ |
17,337
|
||||
Deferred
revenue
|
2,598
|
1,772
|
||||||
Current
portion of long-term debt
|
−
|
107
|
||||||
25,319
|
19,216
|
|||||||
Deferred
revenue
|
3,414
|
2,632
|
||||||
Government
grants
|
−
|
723
|
||||||
Long-term
debt
|
−
|
354
|
||||||
Future
income taxes
|
240
|
−
|
||||||
28,973
|
22,925
|
|||||||
Shareholders’
Equity
|
||||||||
Share
capital
|
150,019
|
148,921
|
||||||
Contributed
surplus
|
4,453
|
3,776
|
||||||
Retained
earnings
|
42,275
|
−
|
||||||
Cumulative
translation adjustment
|
53,418
|
43,537
|
||||||
250,165
|
196,234
|
|||||||
$ |
279,138
|
$ |
219,159
|
Three
months ended
August
31, 2007
|
Twelve
months ended
August
31, 2007
|
Three
months ended
August
31, 2006
|
Twelve
months ended
August
31, 2006
|
|||||||||||||
Sales
|
$ |
42,975
|
$ |
152,934
|
$ |
35,733
|
$ |
128,253
|
||||||||
Cost
of sales (1,2)
|
18,109
|
65,136
|
16,318
|
57,275
|
||||||||||||
Gross
margin
|
24,866
|
87,798
|
19,415
|
70,978
|
||||||||||||
Operating
expenses
|
||||||||||||||||
Selling
and administrative (1)
|
13,035
|
49,580
|
10,857
|
40,298
|
||||||||||||
Net
research and development (1,
3)
|
2,308
|
16,668
|
4,281
|
15,404
|
||||||||||||
Amortization
of property, plant and equipment
|
801
|
2,983
|
871
|
3,523
|
||||||||||||
Amortization
of intangible assets
|
699
|
2,864
|
1,043
|
4,394
|
||||||||||||
Impairment
of long-lived assets
|
−
|
−
|
−
|
604
|
||||||||||||
Government
grants
|
(1,079 | ) | (1,079 | ) |
−
|
(1,307 | ) | |||||||||
Total
operating expenses
|
15,764
|
71,016
|
17,052
|
62,916
|
||||||||||||
Earnings
from operations
|
9,102
|
16,782
|
2,363
|
8,062
|
||||||||||||
Interest
and other income
|
1,204
|
4,717
|
1,074
|
3,253
|
||||||||||||
Foreign
exchange gain (loss)
|
(156 | ) | (49 | ) |
17
|
(595 | ) | |||||||||
Earnings
before income taxes
|
10,150
|
21,450
|
3,454
|
10,720
|
||||||||||||
Income
taxes
|
||||||||||||||||
Current
|
1,232
|
3,741
|
544
|
2,585
|
||||||||||||
Recognition
of previously unrecognized future income tax assets
|
(24,566 | ) | (24,566 | ) |
−
|
−
|
||||||||||
(23,334 | ) | (20,825 | ) |
544
|
2,585
|
|||||||||||
Net
earnings for the period
|
$ |
33,484
|
$ |
42,275
|
$ |
2,910
|
$ |
8,135
|
||||||||
Basic
net earnings per share
|
$ |
0.49
|
$ |
0.61
|
$ |
0.04
|
$ |
0.12
|
||||||||
Diluted
net earnings per share
|
$ |
0.48
|
$ |
0.61
|
$ |
0.04
|
$ |
0.12
|
||||||||
Basic
weighted average number of shares outstanding
(000’s)
|
68,969
|
68,875
|
68,735
|
68,643
|
||||||||||||
Diluted
weighted average number of shares outstanding
(000’s)
|
69,486
|
69,555
|
69,346
|
69,275
|
||||||||||||
(1)
Stock-based compensation costs included
in:
|
||||||||||||||||
Cost
of sales
|
$ |
25
|
$ |
118
|
$ |
16
|
$ |
127
|
||||||||
Selling
and administrative
|
191
|
633
|
142
|
701
|
||||||||||||
Net
research and development
|
61
|
230
|
55
|
204
|
||||||||||||
$ |
277
|
$ |
981
|
$ |
213
|
$ |
1,032
|
|||||||||
(2)
The cost of sales is exclusive of amortization, shown
separately.
|
||||||||||||||||
(3)
Net research and development expenses for the periods ended August
31,
2007 include recognition of unrecognized research and development
tax
credits of $3,162.
|
Retained
earnings (Deficit)
|
||||||||
Twelve
months ended August 31,
|
||||||||
2007
|
2006
|
|||||||
(unaudited)
|
||||||||
Balance
– Beginning of period
|
$ |
−
|
$ | (381,846 | ) | |||
Add
|
||||||||
Net
earnings for the period
|
42,275
|
8,135
|
||||||
Elimination
of deficit by reduction of share capital
|
−
|
373,711
|
||||||
Balance
– End of period
|
$ |
42,275
|
$ |
–
|
Contributed
surplus
|
||||||||
Twelve
months ended August 31,
|
||||||||
2007
|
2006
|
|||||||
(unaudited)
|
||||||||
Balance
– Beginning of period
|
$ |
3,776
|
$ |
2,949
|
||||
Add
(deduct)
|
||||||||
Stock-based
compensation costs
|
973
|
1,027
|
||||||
Reclassification
of stock-based compensation costs to share capital upon exercise
of stock
awards
|
(296 | ) | (200 | ) | ||||
Balance
– End of period
|
$ |
4,453
|
$ |
3,776
|
Three
months ended
August
31, 2007
|
Twelve
months ended
August
31, 2007
|
Three
months ended
August
31, 2006
|
Twelve
months ended
August
31, 2006
|
|||||||||||||
Cash
flows from operating activities
|
||||||||||||||||
Net
earnings for the period
|
$ |
33,484
|
$ |
42,275
|
$ |
2,910
|
$ |
8,135
|
||||||||
Add
(deduct) items not affecting cash
|
||||||||||||||||
Discount
on short-term investments
|
(1,062 | ) | (404 | ) | (872 | ) | (229 | ) | ||||||||
Stock-based
compensation costs
|
277
|
981
|
213
|
1,032
|
||||||||||||
Amortization
|
1,500
|
5,847
|
1,914
|
7,917
|
||||||||||||
Impairment
of long-lived assets
|
−
|
−
|
−
|
604
|
||||||||||||
Gain
on disposal of capital assets
|
(17 | ) | (117 | ) |
−
|
−
|
||||||||||
Future
income taxes
|
(24,566 | ) | (24,566 | ) |
−
|
−
|
||||||||||
Deferred
revenue
|
135
|
1,299
|
538
|
786
|
||||||||||||
Government
grants
|
(730 | ) | (752 | ) |
−
|
(1,307 | ) | |||||||||
9,021
|
24,563
|
4,703
|
16,938
|
|||||||||||||
Change
in non-cash operating items
|
||||||||||||||||
Accounts
receivable
|
792
|
(5,468 | ) |
1,521
|
(2,637 | ) | ||||||||||
Income
taxes and tax credits
|
(2,006 | ) | (3,403 | ) |
1,690
|
329
|
||||||||||
Inventories
|
(2,824 | ) | (5,456 | ) |
803
|
(2,287 | ) | |||||||||
Prepaid
expenses
|
174
|
85
|
260
|
79
|
||||||||||||
Accounts
payable and accrued liabilities
|
1,564
|
4,105
|
(759 | ) | (144 | ) | ||||||||||
6,721
|
14,426
|
8,218
|
12,278
|
|||||||||||||
Cash
flows from investing activities
|
||||||||||||||||
Additions
to short-term investments
|
(80,267 | ) | (807,056 | ) | (34,655 | ) | (673,289 | ) | ||||||||
Proceeds
from disposal and maturity of short-term investments
|
75,073
|
793,435
|
29,845
|
681,500
|
||||||||||||
Additions
to capital assets
|
(2,011 | ) | (5,547 | ) | (847 | ) | (3,378 | ) | ||||||||
Net
proceeds from disposal of capital assets
|
301
|
3,092
|
−
|
−
|
||||||||||||
Business
combination, net cash acquired
|
−
|
−
|
(338 | ) | (18,054 | ) | ||||||||||
(6,904 | ) | (16,076 | ) | (5,995 | ) | (13,221 | ) | |||||||||
Cash
flows from financing activities
|
||||||||||||||||
Repayment
of long-term debt
|
(394 | ) | (472 | ) | (257 | ) | (415 | ) | ||||||||
Exercise
of stock options
|
229
|
802
|
54
|
557
|
||||||||||||
(165 | ) |
330
|
(203 | ) |
142
|
|||||||||||
Effect
of foreign exchange rate changes on cash
|
(119 | ) |
8
|
(148 | ) |
535
|
||||||||||
Change
in cash
|
(467 | ) | (1,312 | ) |
1,872
|
(266 | ) | |||||||||
Cash
– Beginning of period
|
6,008
|
6,853
|
4,981
|
7,119
|
||||||||||||
Cash
– End of period
|
$ |
5,541
|
$ |
5,541
|
$ |
6,853
|
$ |
6,853
|